The National Health and Medical Research Council (NHMRC) – European Union (EU) Collaborative Research Grants scheme aims to provide assistance to Australian researchers to participate in multinational research collaborative projects with international researchers that have been selected for funding under the European Commission’s Horizon 2020 Health, Demographic Change and Wellbeing calls.
Horizon 2020 is the EU's main instrument for funding research and development and it will run from 2014 to 2020. More information on Horizon 2020 is available from the following website:
Projects involving Australian researchers based in Australia that are chosen by the European Commission (EC) for funding, may be eligible for NHMRC support of up to $100,000 per year.
Prior to submission of an application for NHMRC – EU scheme funding, applicants are to ensure they:
- are eligible to apply;
- read all relevant reference material; and
- contact their Administering Institution to identify any specific requirements that the Institution may have.
Eligibility for 2014 is provided so potential applicants to the EU may judge whether their applications are likely to be eligible for NHMRC support. The specific calls NHMRC intends to support through the 2014 round are included below.
Applications must be certified by, and submitted through the Research Administration Office (RAO) of an NHMRC approved Administering Institution.
To be eligible for NHMRC – EU Scheme:
- Only applicants successful through the EU process are eligible to apply to NHMRC.
- All Australian CIs are to be listed on the EU application as key or principal personnel or as participants, and their roles explained. This ensures that the CI’s contribution has been peer reviewed as part of the original EU application. Applications that do not list Australian applicants on the EU application will not be eligible, even if they are subsequently listed on the EU grant agreement;
- The Administering Institution for the NHMRC – EU application must be listed as a Full Partner in the List of Participants in the EU application;
- Evidence, such as a letter from the EU or the EU grant agreement, which indicates that the relevant EU Horizon 2020 application has been favourably evaluated and/or successfully awarded by the European Commission, must be provided as part of the NHMRC-EU application. Where the EU grant agreement is provided, Australian participants must be listed on the agreement;
- Only one NHMRC application will be accepted and funded for each successful EU application. NHMRC recognises that an application to the EU may involve more than one Australian researcher. In this situation, those researchers will need to agree to a lead CI(A) and submit a single application. Other Australian researchers listed on the EU application must be identified as CIs in that application;
- Funding may not be sought where the EU is providing funds for the Australian component;
- CIs must be based in Australia for the duration of the grant;
- Applications must have been submitted to the European Commission under:
- The European Commission’s Seventh Framework Programme (FP7) Cooperation calls; or
- The following Horizon 2020- Societal Challenges – Health, Demographic Change and Wellbeing calls:
- PHC-01-2014: Understanding health, ageing and disease: determinants, risk factors and pathways
- PHC-05-2014: Health promotion and disease prevention: translating 'omics' into stratified approaches
- PHC-06-2014: Evaluating existing screening and prevention programmes
- PHC-07-2014: Improving the control of infectious epidemics and foodborne outbreaks through rapid identification of pathogens
- PHC-10-2014: Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
- PHC-13-2014: New therapies for chronic non-communicable diseases
- PHC-17-2014: Comparing the effectiveness of existing healthcare interventions in the elderly
- PHC-23-2014: Developing and comparing new models for safe and efficient, prevention oriented health and care systems
- PHC-32-2014: Advancing bioinformatics to meet biomedical and clinical needs.
- Provision of the final EU grant agreement is a condition of funding.
- Holding an NHMRC – EU Collaborative Research Grant does not affect a CI’s ability to hold other NHMRC Grants.
- Application opens - anticipated to be in December 2014
- Applications close - anticipated to be in February 2015
Applications submitted after the closing date will not be accepted.
How to apply for grant funding under this program
Responsibility for submitting proposals to the EC under the Horizon 2020 lies with the European partners.
Applications for NHMRC – EU Scheme grants are only required to be submitted to NHMRC if an application has been peer reviewed by the EC and is favourably evaluated for funding. The Australian Chief Investigator A (CIA) must forward evidence that the application has been favourably evaluated, with the Evaluation Summary Report and their application, to the NHMRC by the advertised closing date and time.
The NHMRC’s Research Grants Management System (RGMS) must be used to access/enter your CV and Profile, or submit funding applications to NHMRC.
Applicants who are not yet registered on RGMS should contact the Research Help Centre on firstname.lastname@example.org for more information.
A complete NHMRC – EU Scheme Application must consist of the following:
- Completion of Parts A and B of the application form;
- The relevant information in your RGMS Profile and CV;
- The uploaded PDF document containing your Research Proposal; and
- A copy of the Proposal submitted to the EU and evidence that the application has been favourably evaluated by the EC.
Documentation to apply for a NHMRC – EU Scheme Grant
- To be advised
2015 Personalising Health Care calls NHMRC intends to support
The specific calls NHMRC intends to support through the 2015 round are:
- PHC-03-2015: Understanding common mechanisms of diseases and their relevance in co-morbidities
- PHC-09-2015: Vaccine development for poverty-related and neglected infectious diseases: HIV/AIDS
- PHC-15-2015: Clinical research on regenerative medicine
- PHC-16-2015: Tools and technologies for advanced therapies
- PHC-18-2015: Establishing effectiveness of health care interventions in the paediatric population
- PHC-21-2015: Advancing active and healthy ageing with ICT: Early risk detection and intervention
- PHC-22-2015: Promoting mental wellbeing in the ageing population
For more information please contact:
NHMRC – European Union Collaborative Research Grants
GPO Box 1421
CANBERRA ACT 2601